Table 4.

Treatment coverage of IVM during the second round of 2016 mass drug administration by group

	Modified campaign	Standard CDTI
Number interviewed	1,665	1,697
Reported coverage (over treatment target)	80%	87%
Reported coverage (over total population)	64%	69%
Offered IVM, weighted (95% CI)	41.8% (29.2–54.4%)	42.8% (31.6–52.7%)
IVM coverage, weighted (95% CI)	39.2% (27.4–50.9%)	42.2% (31.6–52.7%)
IVM coverage, weighted, treated EAs only (95% CI)	39.8% (32.2–47,4%)	49.4% (42.4–56.4%)
Geographic coverage (any treatment)	84%	93%

CDTI = community-directed treatment with IVM; CI = confidence intervals; EA = enumeration area; IVM = ivermectin. Neither group reached the target coverage of 80% of the total population.